Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
12/2003
12/25/2003US20030236261 Potassium channel inhibitors
12/25/2003US20030236231 Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
12/25/2003US20030235863 Bead-based detection of ligand-GPCR-G protein complexes
12/24/2003WO2003106689A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE alpha-METHYLCYSTEINE DERIVATIVE
12/24/2003WO2003106429A1 Prodrug and process for producing the same
12/24/2003WO2003106428A1 Novel arylsulphonamide derivatives and use thereof as therapeutic agents
12/24/2003WO2003106419A1 Room-temperature molten salt, process for producing the same and applications thereof
12/24/2003WO2003106402A1 2-naphtamide derivatives
12/24/2003WO2003106401A1 N-bridged selective androgen receptor modulators and methods of use thereof
12/24/2003WO2003105845A1 Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
12/24/2003WO2003084916A3 Compounds that modulate ppar activity and methods for their preparation
12/24/2003WO2003068224A3 Use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases
12/24/2003WO2002092608A3 Use of a composition of an ionic nature as a substrate reagent, a composition constituting a fluorination reagent and a method using same
12/24/2003WO2002028829A3 Peptide deformylase inhibitors
12/24/2003CN1463263A Method to inhibit ethylene responses in plants
12/24/2003CA2489470A1 Prodrug and process for producing the same
12/24/2003CA2489361A1 Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
12/24/2003CA2489286A1 2-naphtamide derivatives
12/24/2003CA2489182A1 N-bridged selective androgen receptor modulators and methods of use thereof
12/24/2003CA2486350A1 Process for producing optically active .alpha.-methylcysteine derivative
12/23/2003US6667404 Retroviral protease inhibiting compounds
12/23/2003US6667345 Derivatives of C2-substituted indan-1-ol systems for the prophylaxis or treatment of obesity
12/23/2003US6667342 Benzenesulfonamide-derivatives and their use as medicaments
12/23/2003US6667335 NMDA (N-methyl-D-aspartate)-receptor subtype selective blockers
12/23/2003US6667334 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
12/23/2003US6667331 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
12/23/2003CA2208032C Substituted amidinonaphthyl ester derivative
12/18/2003WO2003104255A2 Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives
12/18/2003WO2003104237A1 2,7,12,17 alkenyl, aryl and heteroaryl derived from 3,6,13,16-tetraazaporphycene, method, intermediate compound and corresponding utilizations
12/18/2003WO2003103664A1 1,5-disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases
12/18/2003WO2003103567A2 Nitrosodiphenylamine derivatives, compositions comprising them, and the use thereof as antioxidants and spontaneous nitric oxide donors
12/18/2003WO2003074474A3 Multiple-component solid phases containing at least one active pharmaceutical ingredient
12/18/2003WO2003057135A3 Aqueous compositions containing metronidazole
12/18/2003WO2003051795A3 Resin-bonded isonitriles
12/18/2003US20030232998 A 4-imidazolines carboxyl acids or esters as a potent non-steroidal antiinflammatory agents, microbiocides, bactericides, antitumor agents; chemical intermediates
12/18/2003US20030232987 Process for preparing xanthine phosphodiesterase V inhibitors and precursors thereof
12/18/2003US20030232877 1,3-Bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
12/18/2003US20030232870 Multi-substituted imidazolines and method of use thereof
12/18/2003US20030232863 Cathepsin cysteine protease inhibitors
12/18/2003US20030232859 Antiinflammatory agents; for treatment of rheumatoid arthritis and multiple sclerosis
12/18/2003US20030232808 Sulfonyl derivatives
12/18/2003US20030232790 Dihydro-2h-napthalene-1-one inhibitors of ras farnesyl transferase
12/18/2003CA2487977A1 1,5-disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases
12/17/2003EP1371650A1 Activator for peroxisome proliferator-activated receptor
12/17/2003EP1371649A1 Process for producing 5-substituted oxazole compounds and 5-substituted imidazole compounds
12/17/2003EP1370556A1 Metalloproteinase inhibitors
12/17/2003EP1370546A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications
12/17/2003EP1370540A1 Anti-thrombotic carboxylic acid amides, the production thereof and use of the same as medicaments
12/17/2003EP1370539A1 Hiv inhibiting n-aminoimidazole derivatives
12/17/2003EP1370538A1 Metalloproteinase inhibitors
12/17/2003EP1370537A1 Metalloproteinase inhibitors
12/17/2003EP1370536A1 Metalloproteinase inhibitors
12/17/2003EP1370535A1 Metalloproteinase inhibitors
12/17/2003EP1370534A1 Metalloproteinase inhibitors
12/17/2003EP1370533A2 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors
12/17/2003EP1370525A1 Biguanide derivatives
12/17/2003EP1370520A1 Aryl and biaryl compounds having mch modulatory activity
12/17/2003EP1370519A1 Synthetic excitatory amino acids
12/17/2003EP1370255A2 Cdc25 phosphatase inhibitors
12/17/2003EP1206467B1 N-heterocyclic derivatives as nos inhibitors
12/17/2003EP1189889B1 Compositions and methods for inhibiting cell death
12/17/2003CN1462270A Imidazole derivatives or their salts
12/17/2003CN1461749A Preparation method of 2-nitroimidazole
12/17/2003CN1131222C Benzamide derivs and their use as APOB-100 secretion inhibitors
12/17/2003CN1131219C Process for preparation of phenylimidazolidine derives
12/17/2003CN1131217C Phenylazole compound, process for producing the same and drugs for hyperlipemia
12/17/2003CN1131071C Tissue anoxia developing agent and its precursor
12/16/2003US6664412 Method for producing lysine derivative
12/16/2003US6664393 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
12/16/2003US6664353 Heterocyclic alkoxyamines as regulators in controlled radical polymerization processes
12/16/2003US6664262 N-methoxymethyl-5,5-diphenylbarbituric acid
12/16/2003CA2122633C 2-heterocyclicethylamine derivatives and their use as pharmaceuticals
12/11/2003WO2003101992A1 Process for preparing xanthine phosphodiesterase v inhibitors and precursors thereof
12/11/2003WO2003101970A1 Imidazolium cxcr3 inhibitors
12/11/2003WO2003101969A1 Multi-substituded imidazolines and method of use thereof
12/11/2003WO2003101966A1 Method of forming a carbon-carbon or carbon-heteroatom linkage
12/11/2003WO2003101954A2 Nf-kb inhibitors and uses thereof
12/11/2003WO2003101392A2 Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods
12/11/2003WO2003101382A2 Compounds useful in the treatment of anthrax and inhibiting lethal factor
12/11/2003WO2003063781A3 Substituted imidazoles as cannabinoid receptor modulators
12/11/2003WO2003057666A3 Inhibitors of dipeptidyl peptidase iv
12/11/2003WO2003028721A3 Substituted benzimidazole compounds and their use for the treatment of cancer
12/11/2003WO2002083067A3 Prodrugs via acylation with cinnamate
12/11/2003US20030229231 Forming chelate compounds
12/11/2003US20030229132 Small molecule modulators of apoptosis
12/11/2003US20030229130 Imidazolinylmethyl aralkylsulfonamides
12/11/2003US20030229129 Alopecia therapy; skin disorders
12/11/2003US20030229127 Heterocyclic sulfonamide inhibitors of beta amyloid production
12/11/2003US20030229123 2-(Substituted-phenyl)amino-imidazoline derivatives
12/11/2003US20030229110 Cell signal transduction
12/11/2003US20030229109 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
12/11/2003US20030229093 Lipid diseases; metabolism diosrders; antiproliferative agents
12/11/2003US20030229091 Heteroaromatic substituted cyclopropane as corticotropin releasing hormone ligands
12/11/2003US20030229079 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
12/11/2003US20030229076 Therapy for psychological disorders; cardiovascular disorders; antidiabetic agents; central nervous system disorders
12/11/2003US20030229053 Compounds and methods for the treatment or prevention of flavivirus infections
12/11/2003US20030228700 Provides compounds useful as multifunctional labels in proteomics studies; labels are both lysine specific and increase overall sequence coverage obtained in polypeptide mapping by increasing ionization efficiencies
12/11/2003US20030228355 Precipitation of lipid; fineness particle size
12/11/2003CA2487475A1 Method of forming a carbon-carbon or carbon-heteroatom linkage
12/11/2003CA2483923A1 Process for preparing xanthine phosphodiesterase v inhibitors and precursors thereof
1 ... 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 ... 345